Cipher Pharmaceuticals Inc. (NASDAQ: CPHR) announced the Canadian launch of Actikerall™ (0.5% fluorouracil and 10% salicylic acid), indicated for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE